Abstract
We have developed adenovector-based vaccines targeting G and M2 protein of respiratory syncytial virus. Single intranasal vaccination induced robust G protein-specific IgG and IgA responses, as well as M2-specific CD8+ T-cell immunity, and provided protection against RSV A and B infection. These findings suggest that this vaccine combination holds promising potential for effective RSV prevention.
| Original language | English |
|---|---|
| Article number | 139 |
| Journal | npj Vaccines |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2025.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver